Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Latest Posted October 22, 2025
CBD Gummies Recalled Due to Potential Peanut Contamination
On August 26, 2025, Extract Labs recalled certain lots of CBD gummies due to potential product cross-contact with peanuts.
(For tests of related products, see ConsumerLab’s CBD and Hemp Extract Review, which includes our Top Picks among CBD oils, gummies, and capsules.)
People with a peanut allergy should not consume the recalled products, as this could cause hives, swelling, digestive distress, or anaphylaxis, which can be life-threatening.
The recalled products were distributed throughout the United States, Australia, Germany, the United Kingdom, Malaysia, and New Zealand, and can be further identified by the following:
- Sugar-Free Mixed Berry Gummies: 10 mg CBD and 10 mg Δ9-THC per gummy, packaged in 225 cc amber bottles (Lot 25E5082907A, Exp. 07/2027).
- Elderberry 20 mg Gummies: Unlabeled bulk product intended for private-label consignees, containing 20 mg CBD and 20 mg Δ9-THC per gummy (Lot 25JD072107A, Exp. 07/2027).
- Blue Razz 20 mg Gummies: Unlabeled bulk product intended for private-label consignees, containing 20 mg CBD and 20 mg Δ9-THC per gummy (Lot 25JD082307A, Exp. 07/2027).
- Mai Tai 20 mg Gummies: Unlabeled bulk product intended for private-label consignees, containing 20 mg CBD and 20 mg Δ9-THC per gummy (Lot 25JD042507A, Exp. 07/2027).
Consumers with peanut allergies should not consume these products and should discard them or return them to the place of purchase. Those who experience allergic reactions should seek immediate medical attention.
(Use the links above to see the FDA’s recall listings for more details, including lot numbers, quantities, and distribution information.)
See related recalls and warnings:
Discover Health, LLC Warned for Promoting CBD Products for Cancer, Epilepsy, & More
CBD Not Permitted in Gummies, Candies, Cookies, Candy, or Pet Treats, Says FDA
FDA Warns Five Sellers of CBD for Claims of Treating Arthritis, Alzheimer's and More
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
Other Recent Recalls & Warnings
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please visit the FDA MedWatch website.
